Evidence map›Paper›PMID 23405162›Full record

ArticlePloS one2013

Gender disparities in the presentation, management and outcomes of acute coronary syndrome patients: data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2).

Abdulla Shehab, Bayan Al-Dabbagh, Khalid F AlHabib, Alawi A Alsheikh-Ali, Wael Almahmeed, Kadhim Sulaiman, Ahmed Al-Motarreb, Nicolaas Nagelkerke, Jassim Al Suwaidi, Ahmad Hersi and 4 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Gender-based differences among ST-elevation myocardial infarction patients in Egypt: secondary analysis from the ACCA-EAPCI ESC-STEMI registry.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Sex Differences in Acute Coronary Syndromes: A Global Perspective.Journal of cardiovascular development and disease · 2022
    Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Observational
  15. Article
  16. Utility of Imaging in Risk Stratification of Chest Pain in Women.Current treatment options in cardiovascular medicine · 2017
    Review
  17. Review
  18. Statin Adherence: Does Gender Matter?Current atherosclerosis reports · 2016
    Review
  19. Observational
  20. Acute coronary syndromes in women and men.Nature reviews. Cardiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 6 countries.

Abdulla ShehabDepartment of Internal Medicine, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. a.shehab@uaeu.ac.ae
Bayan Al-Dabbagh
Khalid F AlHabib
Alawi A Alsheikh-Ali
Wael Almahmeed
Kadhim Sulaiman
Ahmed Al-Motarreb
Nicolaas Nagelkerke
Jassim Al Suwaidi
Ahmad Hersi
Hussam Al Faleh
Nidal Asaad
Shukri Al Saif
Haitham Amin
King Saud University · SAUnited Arab Emirates University · AEHamad Medical Corporation · QARoyal Hospital · OMSana'a University · YESaud Al-babtain Cardiac Centre · SAShaikh Khalifa Medical City · AETufts University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGender-related differences in mortality of acute coronary syndrome (ACS) have been reported. The extent and causes of these differences in the Middle-East are poorly understood. We studied to what extent difference in outcome, specifically 1-year mortality are attributable to demographic, baseline clinical differences at presentation, and management differences between female and male patients. METHODOLOGY/PRINCIPAL

findingsBaseline characteristics, treatment patterns, and 1-year mortality of 7390 ACS patients in 65 hospitals in 6 Arabian Gulf countries were evaluated during 2008-2009, as part of the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2). Women were older (61.3±11.8 vs. 55.6±12.4; P<0.001), more overweight (BMI: 28.1±6.6 vs. 26.7±5.1; P<0.001), and more likely to have a history of hypertension, hyperlipidemia or diabetes. Fewer women than men received angiotensin-converting enzyme inhibitors (ACE), aspirin, clopidogrel, beta blockers or statins at discharge. They also underwent fewer invasive procedures including angiography (27.0% vs. 34.0%; P<0.001), percutaneous coronary intervention (PCI) (10.5% vs. 15.6%; P<0.001) and reperfusion therapy (6.9% vs. 20.2%; P<0.001) than men. Women were at higher unadjusted risk for in-hospital death (6.8% vs. 4.0%, P<0.001) and heart failure (HF) (18% vs. 11.8%, P<0.001). Both 1-month and 1-year mortality rates were higher in women than men (11% vs. 7.4% and 17.3% vs. 11.4%, respectively, P<0.001). Both baseline and management differences contributed to a worse outcome in women. Together these variables explained almost all mortality disparities. CONCLUSIONS/SIGNIFICANCE: Differences between genders in mortality appeared to be largely explained by differences in prognostic variables and management patterns. However, the origin of the latter differences need further study.

Indexed as

Disease ManagementAcute Coronary SyndromeAngiotensin-Converting Enzyme InhibitorsFemaleHealthcare DisparitiesHospital MortalityHumansMaleMiddle AgedPrognosisProspective StudiesRegistriesRisk FactorsSex FactorsAngiotensin-Converting Enzyme Inhibitors

Identifiers

PMID23405162
PMCPMC3566183
OpenAlexW2062935315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.